MUSUMECI, DOMENICA
 Distribuzione geografica
Continente #
AS - Asia 3.692
EU - Europa 3.308
NA - Nord America 2.998
SA - Sud America 623
AF - Africa 109
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.744
Nazione #
US - Stati Uniti d'America 2.892
SG - Singapore 2.027
RU - Federazione Russa 1.576
IT - Italia 809
CN - Cina 788
BR - Brasile 517
HK - Hong Kong 342
VN - Vietnam 293
DE - Germania 176
NL - Olanda 128
IE - Irlanda 124
FI - Finlandia 109
UA - Ucraina 101
GB - Regno Unito 84
CA - Canada 63
IN - India 52
AR - Argentina 40
CI - Costa d'Avorio 40
SE - Svezia 37
JP - Giappone 29
MX - Messico 29
ZA - Sudafrica 29
FR - Francia 28
ES - Italia 27
KR - Corea 27
EC - Ecuador 24
PL - Polonia 24
BD - Bangladesh 23
BE - Belgio 18
ID - Indonesia 18
PK - Pakistan 15
CO - Colombia 13
IQ - Iraq 12
MA - Marocco 12
SI - Slovenia 12
AT - Austria 8
GR - Grecia 8
NP - Nepal 7
PY - Paraguay 7
TR - Turchia 7
AU - Australia 6
EG - Egitto 6
LT - Lituania 6
VE - Venezuela 6
EU - Europa 5
IL - Israele 5
IR - Iran 5
JO - Giordania 5
KE - Kenya 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
HU - Ungheria 4
LB - Libano 4
BH - Bahrain 3
MY - Malesia 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
LY - Libia 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
SR - Suriname 2
SY - Repubblica araba siriana 2
VC - Saint Vincent e Grenadine 2
AM - Armenia 1
BF - Burkina Faso 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
IS - Islanda 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
Totale 10.732
Città #
Singapore 933
Moscow 414
Chandler 411
Hong Kong 340
Beijing 258
Santa Clara 206
Ashburn 177
Napoli 164
Naples 153
Hefei 122
Amsterdam 109
Los Angeles 97
Ho Chi Minh City 95
Millbury 94
Nanjing 90
Jacksonville 84
Princeton 84
Des Moines 67
Hanoi 55
Buffalo 52
Munich 49
New York 47
Milan 46
São Paulo 46
Boston 45
The Dalles 42
Wilmington 41
Redondo Beach 39
Ottawa 35
Houston 33
Rome 33
Dallas 32
Dong Ket 28
Lawrence 28
Seoul 25
Chicago 24
Ann Arbor 22
Warsaw 21
Woodbridge 20
Denver 19
San Jose 19
Montreal 18
Seattle 18
Jiaxing 17
Rio de Janeiro 17
Tianjin 17
Tokyo 16
Nanchang 15
Redwood City 15
Mexico City 14
Brooklyn 13
Changsha 13
Frankfurt am Main 13
Helsinki 13
Johannesburg 13
Madrid 13
Turku 13
Belo Horizonte 12
Curitiba 12
Falkenstein 12
Haiphong 12
Hebei 12
Nuremberg 12
Orem 12
Porto Alegre 12
Shenyang 12
Stockholm 12
Boardman 11
Dublin 11
Guangzhou 11
Kochi 11
Norwalk 11
Caserta 10
Brussels 9
Da Nang 9
Guayaquil 9
Phoenix 9
Portici 9
Atlanta 8
Biên Hòa 8
Brasília 8
Düsseldorf 8
Fairfield 8
Hải Dương 8
Indiana 8
London 8
Ninh Bình 8
Poplar 8
Shanghai 8
Goiânia 7
Lappeenranta 7
Salerno 7
Torre del Greco 7
Casablanca 6
Charlotte 6
Chennai 6
Guarulhos 6
Sydney 6
Zhengzhou 6
Amman 5
Totale 5.324
Nome #
Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides 178
Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes 165
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 146
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 145
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 137
Monitoring changes in the spectroscopic properties of ODN nanoconjugates 136
Remote control of biomolecules by radiofrequency: a test study 134
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 130
Lipooligosaccharides as Amphiphiles to Build Liposomes for Effective Drug Delivery: The Case of Anticancer Ruthenium Complex-Based Aggregates 125
On the binding of naphthalene diimides to a human telomeric G-quadruplex multimer model 124
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 123
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach 121
Tailoring a lead-like compound targeting multiple G-quadruplex structures 120
Preliminary report on a radiofrequency controlled biosensor 119
Interference of polydatin/resveratrol in the ACE2:Spike recognition during COVID-19 infection. a focus on their potential mechanism of action through computational and biochemical assays 117
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 116
Selection of RNA aptamers targeting hypoxia in cancer 114
Alternate dab-aegPNAs: synthesis, nucleic acid binding studies and biological activity 111
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 111
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 111
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 110
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 110
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 108
Evidences of complex formation between DABA-based nucleo-gamma-peptides with alternate configuration backbone 108
Synthesis and supramolecular assembly of 1,3-bis(1′-uracilyl)-2- propanone 108
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 107
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 106
Magnetic nanoparticles as effective energy transducers to activate biological nanomachines by means of RF electromagnetic signals 106
NUCLEO-OMICS24 104
Cationic peptides as RNA compaction agents: A study on the polyA compaction activity of a linear alpha,epsilon-oligo-l-lysine 104
Controlled Pore Glass-based oligonucleotide affinity support: towards High Throughput Screening methods for the identification of conformation-selective G-quadruplex ligands 104
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 104
The role of G-quadruplex structures of LIGS-generated aptamers R1.2 and R1.3 in IgM specific recognition 104
Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin 104
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 103
Oxidation of some conjugated diene steroids by hydrogen peroxide catalyzed by methyltrioxorhenium 101
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase 101
DNA- and RNA-binding ability of oligoDapT, a nucleobase-decorated peptide, for biomedical applications 101
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 101
Secosteroids of marine origin 100
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 100
Natural and artificial binders of polyriboadenylic acid and their effect on RNA structure 99
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 98
Method for the preparation of a low unspecific binding-support for affinity chromatography and/or on-line synthesis of oligonucleotides 98
Metodo per la preparazione di un supporto a basso legame aspecifico per cromatografia di affinità e/o sintesi diretta di oligonucleotidi 98
Dna binding mode analysis of a core-extended naphthalene diimide as a conformation-sensitive fluorescent probe of g-quadruplex structures 98
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 97
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 97
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 97
A new design for nucleolipid-based Ru(III) complexes as anticancer agents 95
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 95
Inhibition of cytokine activity by improved DNA-based ligands 94
Synthesis of Polyoxygenated Steroids with Transition Metal-Based Oxidants: Methyltrioxorhenium-Hydrogen Peroxide System, Ruthenium Tetraoxide, Osmium Tetraoxide and Potassium Permanganate 93
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 93
A short PNA targeting coxsackievirus B3 5'-nontranslated region prevents virus-induced cytolysis 91
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 91
8-CF3-2’-deoxyguanosine as a useful nucleoside analog for 19F NMR-based structural studies of G-quadruplex structures 90
Thiophenyl-substituted triazolyl-thione l-alanine: asymmetric synthesis, aggregation and biological properties 90
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 89
Solid phase synthesis and RNA-binding activity of an arginine-containing nucleopeptide 89
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 89
Towards an analytical methodology for the screening of G-quadruplex-binding ligands 87
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 87
Bent Oligonucleotide Duplexes as HMGB1 Inhibitors: a Comparative Study 86
Controllo di nanomacchine mediante campi elettromagnetici 85
A new route to polyoxygenate C and D rings of steroids by oxidation of a D8,14-diene steroid with the methyltrioxorhenium-H2O2-urea system 85
Looking for new efficient G-quadruplex binders 85
From prebiotic chemistry to supramolecular biomedical materials: Exploring the properties of self‐assembling nucleobase‐containing peptides 85
New 3’-3’ linkers for alternate strand triple helix forming oligodeoxyribonucleotides 84
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 84
Branched oligonucleotides as CathepsinG inhibitors 82
An alternative strategy to synthesize PNA and DNA magnetic conjugates forming nanoparticle assembly based on PNA/DNA duplexes 82
CH3ReO3-catalyzed oxidation of cholesta-5,7-dien-3beta-yl acetate with the urea-hydrogen peroxide adduct under various conditions. Synthesis of the natural epoxy sterol 9α,11α-epoxy-5α-cholest-7-en-3β,5,6β-triol 81
Synthesis of a novel benzodifuran derivative and its molecular recognition of poly rA RNA 80
The oxidation of Delta2, Delta2,4 and Delta4,6 steroids with RuO4 79
Evidences for complex formation between L-dabPNA and aegPNA 79
Binding ability of a thymine-functionalized oligolysine towards nucleic acids 79
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 78
Dakin-West reaction on 1-thyminyl acetic acid for the synthesis of 1,3-bis(1-thyminyl)-2-propanone, a heteroaromatic compound with nucleopeptide-binding properties 78
Synthesis and characterization of new 3’-3’ linked oligodeoxyribonucleotides for alternate strand triple helix formation 77
Trifunctionalized naphthalene diimides and dimeric analogues as g-quadruplex-targeting anticancer agents selected by affinity chromatography 77
Synthesis and characterization of a novel L-tyrosine-based nucleopeptide for biomedical applications 76
dabPna: Design, Synthesis, And Dna Binding Studies 75
Fluorine-containing nucleosides for 19F NMR-based structural studies of nucleic acids: synthesis and characterization of 8-CF3-2’-deoxyguanosine 75
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies 75
Nucleobase-containing peptides: a spectroscopic study of their properties and nucleic acids recognition ability 72
Selective Targeting of Cancer-Related G-Quadruplex Structures by the Natural Compound Dicentrine 72
Synthesis of a cholesteryl-HEG phosphoramidite derivative and its application to lipid-conjugates of the anti-HIV 5'TGGGAG3' Hotoda's sequence. 70
New synthesis of PNA-3'DNA linker monomers, useful building blocks to obtain PNA/DNA chimeras 69
Reactions of 1,5-dienes with ruthenium tetraoxide 69
Reactivity of steroidal dienes towards the methyltrioxorhenium/H2O2-urea oxidation system: isolation and characterization of new oxygenated steroids 68
Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer 68
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 68
Strategie per analisi di sequenze oligonucleotiche: coniugati DNA-nanocristalli 66
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 66
ODN-Based Drugs for Targeting of Extracellular Proteins 65
Epossidazione di dieni coniugati steroidici mediante l’addotto H2O2-Urea catalizzata da metalli di transizione 65
G-Quadruplex on Oligo Affinity Support (G4-OAS): An Easy Affinity Chromatography-Based Assay for the Screening of G-Quadruplex Ligands 65
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 64
Solid phase synthesis and RNA-binding studies of a serum-resistant nucleo-epsilon-peptide 64
Totale 9.610
Categoria #
all - tutte 36.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 0 25 15 51 21 23 31
2021/2022630 8 2 2 17 6 30 15 27 141 14 144 224
2022/20231.015 118 79 28 89 108 114 20 98 146 127 68 20
2023/2024582 25 119 82 30 28 49 20 60 12 9 98 50
2024/20253.402 163 199 22 45 82 222 273 199 240 348 1.299 310
2025/20263.866 644 546 682 541 1.147 280 26 0 0 0 0 0
Totale 10.956